Visit http://MyHealthStory.me for more info. The basic idea is to share short video stories about your healthcare experiences as a patient, family member, or healthcare professional. This is done by uploading these into your own YouTube account and adding a little tag that makes the system find the videos.
The project leader Lucien Engelen provides some background info:
Please have in mind that by recording your video story you voluntarily reveal elements of your (or your relative or friend) protected health information as defined by the HIPAA law in the U.S. This is similar to sharing your personal experience on a blog or any other website.
The new data by CDC and NIH show that 94% of US adults score at a “poor” level on at least one of those factors and that 38% have at least 3 factors at a poor level.
The newly launched "Mayo Clinic News Network" is billed as the journalists' multimedia source for health, science and research information: http://newsnetwork.mayoclinic.org
The no cost, password-protected site for journalists offers the latest breaking medical news, videos, graphics, links for background, animation, experts and patient interviews. Journalists from TV, radio, newspaper, blogs, and mobile platforms are invited to visit our site http://newsnetwork.mayoclinic.org and register. Pending approval, you will have access to this rich source of multimedia content.
I feature high-quality videos from Mayo Clinic on CasesBlog 2-3 times per month, and after some brief consideration I registered and applied for access. I will let you know if a medical blog with 7 million page views qualifies for access to the Mayo Clinic News Network or not (update: the application was approved).
The flagship journal of ACP, Annals of Internal Medicine, already includes medical bloggers in their embargoed news release before each new issue.
The ACP Internist website took a step further and includes guest posts from hand-picked medical bloggers (disclaimer: I am one of the selected authors). Many of the posts are quite interesting and cover a wide variety of topics. You can see for yourself here: http://blog.acpinternist.org
Health Care in the United States has changed over the past several decades for those who receive, provide and pay for care. So, what is the status of U.S. health care today and the trends that emerged in the last 30 years? Catherine Dolf explains in this week's JAMA Report:
The influence of celebrity status is a deeply rooted process that can be harnessed for good or abused for harm. Just a few examples:
- When journalist Katie Couric televised her colonoscopy on NBC’s Today Show in 2000, colorectal cancer screenings by 400 American endoscopists increased by 21% the next month.
- Following actor-singer Kylie Minogue’s diagnosis of breast cancer, bookings for mammograms rose by 40% in four Australian states.
- Many celebrities have mobilized their influence for good. Actor Michael J Fox’s foundation has raised over $350m for research into Parkinson’s disease, whereas singer Sir Elton John’s charity has raised more than $300m towards research into HIV/AIDS.
- British television presenter Sir Michael Parkinson promoted an unsupported self diagnosis technique for prostate cancer based on his own experiences: “The test is if you can pee against a wall from two feet, you haven’t got it.”
A better understanding of celebrity can empower health professionals to take this phenomenon seriously and use patient encounters to educate the public about sources of health information and their trustworthiness.
People are trusting celebrities with their health. Public health authorities could implement regulations and restrictions on celebrity endorsements and design counter marketing initiatives—perhaps even partnering with celebrities—to discredit bogus medical advice while promoting evidence based practices.
From WSJ: More than ever, learning to code seems to be in. Is it for you? The WSJ's journalist gets her first lesson with Sal Khan, founder of the free video education platform Khan Academy.
The project is led by John Resig. The new platform targets people with no programming knowledge and gives them an engaging and fun environment to learn in.
Here is a video introduction of what they have released:
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
Health News of the Day is a daily summary made from the selected links I post on Twitter. It is in a bullet points format with links to the original sources which include 350 RSS feeds that produce about 2,500 items per day:
Advances in multiple sclerosis treatment from NEJM: Treatment with cladribine tablets reduced MS relapse rates, the risk of disability progression, and MRI measures http://bit.ly/8g2lyG -- Oral fingolimod improved the MS relapse rate, the risk of disability progression, and end points on MRI http://bit.ly/7RNMyr -- Oral fingolimod was superior to interferon beta-1a IM with respect to relapse rates and MRI outcomes in MS http://bit.ly/6DFJCj
Addition of monoclonal antibodies against C. difficile toxins to antibiotics reduced the recurrence of C. diff. http://bit.ly/7TCPxg
Erythropoiesis-Stimulating Agents — Time for a Reevaluation - NEJM http://bit.ly/4Ig0aq
Accelerating the Use of Electronic Health Records in Physician Practices - NEJM http://bit.ly/8YuxCX
More than 1,400 protein-rich insect species are regularly enjoyed as food by humans around the world http://bit.ly/8N2BVK
Medical news tweets are not research articles - they are 140-character messages - please always go to the original source, links, etc. Tweets and links do not represent endorsement, approval or support. Image source: OpenClipArt.org, public domain.
@drval: "I'm actually going to stay away from Buzz for a while. I like keeping my email a separate world. Will jump in if it becomes relevant."
ePatientDave: "To me what Buzz means is that Google has permanently shown themselves not qualified to be in health data. Period."
EdBennett: "I'm moving away from all Google apps. it will take time and effort, but this latest gaffe has me worried"
I use Google for most of my online work and I am not planning to change this. However, I do appreciate an alternative point of view.
Comments:
Dean Giustini - Google is throwin' everything at us and I feel buried informationally. I also don't know the point of having Google Wave & Buzz in light of Twitter and all the microblogging aggregators. I never thought it would happen: I've reach info-sat (saturation).
Tim Sturgill - I understand the concern about privacy issue and what occurred with the start of Buzz, but I have some difficulty with the notion that such a wonderful free service (Google products) somehow equates to no personal responsibility. Any privacy "breaches" with the start of Buzz were totally preventable by beforehand looking at and managing your Google profile and reading the instructions that came with the Buzz start. Could Google have done better, sure.
The irony (having had my identity stolen in the hospital I work at and was a patient) -- I'll trust Google with private info, even health info, any day of the week over healthcare entities (without a lot of upfront scrutiny).9:15 pm
Ves Dimov, M.D. - The greatest benefit is that you can actually have a conversation on Buzz, include rich media included and use groups of people to collaborate.
Twitter is an inefficient way of exchanging one-liners. It's probably good for company customer service.
There is a big difference between Buzz and Wave. Buzz is simple micro-blog & network. Google Wave is a powerful collaboration platform in early beta.
Google Wave can replace both Gmail and Google Docs. It is not easy to comprehend for many users though and it is not very intuitive. On the other hand, Google Wave has the functionality but does not have the social network of Buzz and Gmail, hence both services are needed.
The information overload is another topic beyond the scope of this discussion. As I have mentioned, Twitter and Facebook are among the most inefficient ways of information consumption. Google Reader is one of the tools to work with large volumes of info but it is not very "social".
Tim Sturgill - Should have added, any new service (or add on to existing service) should be opt-in not opt-out. So on that score alone I believe Google blew it (but only to the extent you negate any personal responsibility or your persona on the web).
Ves Dimov, M.D. - I agree with you, Tim. Yet, obviously a lot of people feel differently about Google and online privacy in general and their scrutiny is welcome.
Tim Sturgill - Wave goes beyond the web, because of XMPP -- operate independent from the web. A very powerful transport capability is introduced with Wave.
Mayo Clinic video: Looking to start the new year off healthy? Dr. Larry Bergstrom, an integrative medicine specialist at Mayo Clinic in Arizona, explains the 3 elements of good health:
1. exercise 2. nutrition 3. stress reduction.
Participation in sport is associated with a with a 20—40% reduction in all-cause mortality compared with non-participation. Exercise might also be considered as a fifth vital sign, according to the Lancet: http://goo.gl/gyxYf
Related reading:
Minimum amount of physical activity for reduced mortality and extended life expectancy: 15 minutes a day or 90 minutes a week. Lancet, 2011.
Forming a healthy habit is a marathon, not a sprint - start small, the 66th time's the charm. Chicago Tribune, 2011.
